<DOC>
	<DOCNO>NCT00079248</DOCNO>
	<brief_summary>RATIONALE : Hormone replacement therapy may effective relieving symptom menopause , hot flash , night sweat , vaginal dryness , without cause recurrence breast cancer . PURPOSE : This randomized clinical trial study hormone replacement therapy see well work relieve symptom menopause postmenopausal woman previous stage I stage II breast cancer .</brief_summary>
	<brief_title>Hormone Replacement Therapy Relieving Menopausal Symptoms Postmenopausal Women With Previous Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare disease-free survival overall survival postmenopausal woman prior stage I II breast cancer treat hormone replacement therapy ( HRT ) vs nonhormonal alternative HRT . - Compare relief menopausal symptom quality life patient treat regimen . - Compare cardiovascular osteoporotic event patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , age ( &lt; 40 year vs ≥ 40 year ) , year diagnosis ( ≤ 2 v &gt; 2 &lt; 5 v ≥ 5 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral transdermal HRT comprise estrogen without progesterone least 2 year . - Arm II : Patients offer advice nonhormonal HRT alternative . Menopausal symptom assess baseline , 3 , 6 , 12 month , every 6 month 4 year , annually thereafter . Quality life assess baseline , 3 , 6 , 12 month , every 6 month 1 year , annually thereafter . Patients follow every 6 month 3 year annually thereafter . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 2,800-3,000 patient ( 1,400-1,500 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Prior diagnosis stage I II breast cancer No clinical evidence recurrence Meets criteria 1 following : Amenorrheic least past 6 month Radiotherapy chemicallyinduced ovarian suppression allow Prior surgical bilateral oophorectomy Experiencing vasomotor symptom ( i.e. , hot flash night sweat ) without vaginal dryness No undiagnosed postmenopausal bleed No ductal carcinoma situ lobular carcinoma situ alone Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age Postmenopausal Sex Female Menopausal status Postmenopausal Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic No severe , active liver disease abnormal liver function test No acute , intermittent porphyria Fibrinolysis coagulation normal Renal Not specify Cardiovascular No prior deep vein thrombosis Thrombophlebitis superficial phlebitis alone allow No prior retinal vein thrombosis Pulmonary No prior pulmonary embolism Other Not pregnant No prior alcohol , drug , chemical abuse No prior concurrent malignancy except nonmelanoma skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No concurrent chemotherapy Endocrine therapy More 3 month since prior oral transdermal hormone replacement therapy ( HRT ) More 5 year since prior HRT implant No concurrent HRT No concurrent gonadotropinreleasing hormone agonist ( e.g. , goserelin ) less 2 year plan treatment remain No concurrent lowdose progestins No concurrent tibolone No concurrent phytoestrogens ( e.g. , black cohosh , red clover , soy ) Radiotherapy See Disease Characteristics Surgery See Disease Characteristics Other No concurrent Hypericum perforatum ( St. John 's wort )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>menopausal symptom</keyword>
	<keyword>hot flash</keyword>
</DOC>